Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day By: MarketWatch November 04, 2022 at 10:21 AM EDT Pfizer Inc. and Germany-based partner BioNTech said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a "substantially higher" immune response in adults than the original COVID-19 vaccine. Read More >> Related Stocks: Biontech Se ADR Pfizer Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day By: MarketWatch November 04, 2022 at 10:21 AM EDT Pfizer Inc. and Germany-based partner BioNTech said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a "substantially higher" immune response in adults than the original COVID-19 vaccine. Read More >> Related Stocks: Biontech Se ADR Pfizer
